Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $51

Truist Securities analyst David Macdonald has reiterated a Buy rating on Guardian Pharmacy Service (NYSE: GRDN) and increased the price target from $47 to $51. This adjustment reflects a positive outlook for the company in the market.